Desq Long
Sign in

Company

C4 Therapeutics, Inc.

CCCC · CIK 0001662579

SEC FORM 4
$14,500.52

C4 Therapeutics, Inc. (CCCC)

Acquisition (code A) of 4,618 shares at $3.14 per share.

Reporting Person GROGAN DONNA ROY · Transaction Code A

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001470831-26-000924 · filed 2026-10-02 · View filing →

SEC FORM 4
$11,498.68

C4 Therapeutics, Inc. (CCCC)

Acquisition (code A) of 3,662 shares at $3.14 per share.

Reporting Person Anderson Kenneth Carl · Transaction Code A

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001470831-26-000925 · filed 2026-10-02 · View filing →

SEC FORM 4
$0.00

C4 Therapeutics, Inc. (CCCC)

Acquisition (code M) of 6,250 shares at $0 per share.

Reporting Person Adams Kendra · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001470831-26-000895 · filed 2026-09-21 · View filing →

SEC FORM 4
$9,407.25

C4 Therapeutics, Inc. (CCCC)

Disposition (code F) of 2,775 shares at $3.39 per share.

Reporting Person Adams Kendra · Officer Title Chief Financial Officer · Transaction Code F

Traded Sep 18, 2026 · Disclosed Sep 21, 2026

Source: SEC Form 4 · 0001470831-26-000895 · filed 2026-09-21 · View filing →